Prognostic factors and treatment outcome of mantle cell and low grade follicular non hodgkin lymphoma / Mohamed Emam Salah Emam ; Supervised Osman Mohamed Mansour , Thoraya Mohamed Abdelhamid , Asmaa Ibrahim Abdelaziz

By:

Mohamed Emam Salah Emam

Contributor(s):

Material type: Text

TextLanguage: English Publication details: Cairo : Mohamed Emam Salah Emam , 2018Description: 150 P. : charts ; 25cmOther title:

العوامل التنبئية والأثر العلاجي في حالات سرطان الغدد الليمفاوية قليل الدرجة من نوعية الخلايا الدرعية والخلايا العقدية : دراسة مرجعية [Added title page title]

Subject(s):

Available additional physical forms:

Issued also as CD

Dissertation note: Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology (Medical ) Summary: Background:Follicular lymphoma (FL), commonly referred to as an indolent lymphoma, is the second most common type of non-Hodgkin lymphoma. Median survival rates have historically reported to be in the range of 8 to 10 years. Mantle cell lymphoma (MCL) is an uncommon B-cell malignancy subtype that was officially classified as a distinct class of non-Hodgkin lymphoma. Epidemiological risk factors are incompletely defined, with data to suggest both inherited and exogenous triggers related to the development of this malignancy. Aim of the study: to assess clinical prognostic factors and survival outcome for all patients with Mantle Cell Lymphoma and Low-Grade Follicular presented to the National Cancer Institute between the periods of January 2008 to December 2016. Patients and methods: our retrospective study included 85 patients pathologically proven to be low grade follicular NHL and 26 patients pathologically proven to be Mantle cell lymphoma. Result: among 85 patients pathologically proven to be low grade follicular NHL showed median age 53 years (range 28 to 85years) with female predominance Ann Arbor stage IV is the most encountered stage.Complete response is achieved in 38.8% of the patients. Median follow up period is 14.3 months & median PFS is 10.8 months

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Copy number	Status	Date due	Barcode
Thesis	قاعة الرسائل الجامعية - الدور الاول	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.19.04.M.Sc.2018.Mo.P (Browse shelf(Opens below))		Not for loan		01010110077292000
CD - Rom	مخـــزن الرســائل الجـــامعية - البدروم	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.19.04.M.Sc.2018.Mo.P (Browse shelf(Opens below))	77292.CD	Not for loan		01020110077292000

Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology (Medical )

Background:Follicular lymphoma (FL), commonly referred to as an indolent lymphoma, is the second most common type of non-Hodgkin lymphoma. Median survival rates have historically reported to be in the range of 8 to 10 years. Mantle cell lymphoma (MCL) is an uncommon B-cell malignancy subtype that was officially classified as a distinct class of non-Hodgkin lymphoma. Epidemiological risk factors are incompletely defined, with data to suggest both inherited and exogenous triggers related to the development of this malignancy. Aim of the study: to assess clinical prognostic factors and survival outcome for all patients with Mantle Cell Lymphoma and Low-Grade Follicular presented to the National Cancer Institute between the periods of January 2008 to December 2016. Patients and methods: our retrospective study included 85 patients pathologically proven to be low grade follicular NHL and 26 patients pathologically proven to be Mantle cell lymphoma. Result: among 85 patients pathologically proven to be low grade follicular NHL showed median age 53 years (range 28 to 85years) with female predominance Ann Arbor stage IV is the most encountered stage.Complete response is achieved in 38.8% of the patients. Median follow up period is 14.3 months & median PFS is 10.8 months

Issued also as CD

There are no comments on this title.

to post a comment.